Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antianhedonic Effect of Repeated Ketamine Infusions in Patients With Treatment Resistant Depression
Alina Wilkowska, Mariusz S. Wiglusz, Maria Gałuszko‐Węgielnik, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions
Roger S. McIntyre, Mohammad Alsuwaidan, Bernhard T. Baune, et al.
World Psychiatry (2023) Vol. 22, Iss. 3, pp. 394-412
Open Access | Times Cited: 256
Changes in white matter microstructure following serial ketamine infusions in treatment resistant depression
Brandon Taraku, Roger P. Woods, Michael Boucher, et al.
Human Brain Mapping (2023) Vol. 44, Iss. 6, pp. 2395-2406
Open Access | Times Cited: 16
Low-carbohydrate diet as a nutritional intervention in a major depression disorder: focus on relapse prevention
Michał Walaszek, Zofia Kachlik, Wiesław Jerzy Cubała
Nutritional Neuroscience (2024), pp. 1-14
Closed Access | Times Cited: 6
Anhedonia in bipolar depression treated with ketamine
Alina Wilkowska, Mariusz S. Wiglusz, Aleksandra Arciszewska, et al.
Bipolar Disorders (2024) Vol. 26, Iss. 4, pp. 356-363
Closed Access | Times Cited: 6
Chemogenetics identifies separate area 25 brain circuits involved in anhedonia and anxiety in marmosets
Christian M. Wood, Laith Alexander, Johan Alsiö, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 690
Open Access | Times Cited: 13
Ketamine treatment for anhedonia in unipolar and bipolar depression: a systematic review
Aleksander Kwaśny, Julia Kwaśna, Alina Wilkowska, et al.
European Neuropsychopharmacology (2024) Vol. 86, pp. 20-34
Closed Access | Times Cited: 5
Effect of Ketamine on Sleep in Treatment-Resistant Depression: A Systematic Review
Aleksander Kwaśny, Adam Włodarczyk, Damian Ogonowski, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 4, pp. 568-568
Open Access | Times Cited: 12
Exploring the Molecular Targets for the Antidepressant and Antisuicidal Effects of Ketamine Enantiomers by Using Network Pharmacology and Molecular Docking
Glorister A. Altê, Ana Lúcia S. Rodrigues
Pharmaceuticals (2023) Vol. 16, Iss. 7, pp. 1013-1013
Open Access | Times Cited: 11
Review: The use of functional magnetic resonance imaging (fMRI) in clinical trials and experimental research studies for depression
Vasileia Kotoula, Jennifer W. Evans, Claire Punturieri, et al.
Frontiers in Neuroimaging (2023) Vol. 2
Open Access | Times Cited: 10
Anhedonia and depression severity measures during ketamine administration in treatment-resistant depression
Aleksander Kwaśny, Wiesław Jerzy Cubała, Adam Włodarczyk
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 3
Preliminary evidence that ketamine alters anterior cingulate resting-state functional connectivity in depressed individuals
Laith Alexander, Peter C.T. Hawkins, Jennifer W. Evans, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 8
Anhedonia modulates benzodiazepine and opioid demand among persons in treatment for opioid use disorder
Mark K. Greenwald, Tabitha E.H. Moses, Leslie H. Lundahl, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 7
The Use of Ketamine for the Treatment of Anhedonia in Depression
Liliana Patarroyo-Rodríguez, Stefanie Cavalcanti, Jennifer L. Vande Voort, et al.
CNS Drugs (2024) Vol. 38, Iss. 8, pp. 583-596
Closed Access | Times Cited: 2
IN Esketamine and IV Ketamine: Results of a multi-site observational study assessing the effectiveness and tolerability of two novel therapies for treatment-resistant depression
Gilmar Gutiérrez, Jennifer Swainson, Nisha Ravindran, et al.
Psychiatry Research (2024) Vol. 340, pp. 116125-116125
Open Access | Times Cited: 2
Ketamine use in pediatric depression: A systematic review
Shakila Meshkat, Joshua D. Rosenblat, Roger Ho, et al.
Psychiatry Research (2022) Vol. 317, pp. 114911-114911
Closed Access | Times Cited: 10
An Update on the Efficacy of Single and Serial Intravenous Ketamine Infusions and Esketamine for Bipolar Depression: A Systematic Review and Meta-Analysis
Nicolás A. Núñez, Boney Joseph, Rakesh Kumar, et al.
Brain Sciences (2023) Vol. 13, Iss. 12, pp. 1672-1672
Open Access | Times Cited: 5
Modulation of habenular and nucleus accumbens functional connectivity by ketamine in major depression
Brandon Taraku, Joana Loureiro, Ashish Sahib, et al.
Brain and Behavior (2024) Vol. 14, Iss. 6
Open Access | Times Cited: 1
The Anti-anhedonic Effects of Ketamine in the Treatment of Resistant Unipolar and Bipolar Depression: A Systematic Review and Meta-analysis of Current Data
Thales Marcon Almeida, Igor Prado Generoso, Diego Augusto Alves Rosa, et al.
Journal of Affective Disorders Reports (2024) Vol. 17, pp. 100829-100829
Open Access | Times Cited: 1
Exploring the Molecular Targets for the Antidepressant and Antisuicidal Effects of Ketamine Enantiomers by using Network Pharmacology and Molecular Docking
Glorister A. Altê, Ana Lúcia S. Rodrigues
(2023)
Open Access | Times Cited: 3
Effect of Acute Ketamine Treatment on Sympathetic Regulation Indexed by Electrodermal Activity in Adolescent Major Depression
Veronika Kováčová, Andrea Macejova, Ingrid Tonhajzerová, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 3, pp. 358-358
Open Access
Successful treatment for serious depression with suicidal risk in a heart transplant patient
María del Mar Arango-Posada, Ana Isabel Prada-Escobar, Carolina Marín-Hernández, et al.
Revista Colombiana de Psiquiatría (English ed ) (2024) Vol. 53, Iss. 2, pp. 210-216
Closed Access
From antidepressants and psychotherapy to oxytocin, vagus nerve stimulation, ketamine and psychedelics: how established and novel treatments can improve social functioning in major depression
Aleksandra Kupferberg, Gregor Hasler
Frontiers in Psychiatry (2024) Vol. 15
Open Access
Anhedonia is associated with a specific depression profile and poor antidepressant response
Antonina Luca, Maria Antonietta De Luca, Siegfried Kasper, et al.
The International Journal of Neuropsychopharmacology (2024) Vol. 27, Iss. 12
Open Access
Sustaining the benefits of intravenous ketamine with behavioural activation therapy for depression: A case series
Jennifer L. Phillips, Pierre Blier, Jeanne Talbot
Journal of Affective Disorders Reports (2023) Vol. 14, pp. 100613-100613
Open Access | Times Cited: 1
Ketamine treatment modulates habenular and nucleus accumbens static and dynamic functional connectivity in major depression
Brandon Taraku, Joana Loureiro, Ashish Sahib, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top